Evidence-backed food-as-medicine at the point of care, paired with the Allie AI companion, voice check-ins, and condition-pack modularity. The interop surface that value-based contracts expect.

Medicare Advantage SSBCI, Medicaid 1115 HRSN, and commercial plan playbooks. Outcome evidence, RFP readiness, and supplemental benefit design.

Referral workflows, RD-led protocols, CDS Hooks integration, and FHIR MeasureReport export. Reduce care gaps without expanding staff.

Aledade, agilon, Privia-style frameworks: attribution, risk-share, and population-level dashboards. Built for ACO REACH and MSSP.
Pillars and spokes built around what payers, providers, and ACOs actually need to defend in committees and bids.
A 2026 executive brief: GLP-1 spend, SSBCI evidence, Stars HEI, and 1115 HRSN.
Why data silos are the enemy of clinical efficacy and how to bridge home and clinic.
Identifying mental health shifts 3x faster through ambient, voice-first AI check-ins.
Choosing the right nutrition modality for short-term recovery vs long-term management.
What VBID sunset means for MA bids, and how to defend the evidence standard.
The actuarial case: 1.5–3:1 medical-cost offset, Stars impact, and HEI revenue.
Turning informal caregiver support into a measurable clinical asset.
We’ll walk through outcome evidence, member journeys, and the interop surface, plus how the program lands in your specific population.